These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34351074)

  • 1. Individual patient data meta-analysis of the effects of the CARILLON® mitral contour system.
    Giallauria F; Di Lorenzo A; Parlato A; Testa C; Bobbio E; Vigorito C; Coats AJS
    ESC Heart Fail; 2020 Dec; 7(6):3383-3391. PubMed ID: 34351074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Mitral Valve Annuloplasty in Patients With Secondary Mitral Regurgitation and Severe Left Ventricular Enlargement.
    Anker SD; Starling RC; Khan MS; Friede T; Filippatos G; Lindenfeld J; von Bardeleben RS; Coats AJS; Butler J
    JACC Heart Fail; 2021 Jun; 9(6):453-462. PubMed ID: 33992567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CINCH-FMR postmarket registry: Real-world long-term outcomes with percutaneous mitral valve repair with the Carillon Mitral Contour System®.
    Yildiz M; Haude M; Sievert H; Fichtlscherer S; Lehmann R; Klein N; Witte K; Degen H; Pfeiffer D; Goldberg SL
    Cardiovasc Revasc Med; 2024 Mar; 60():35-40. PubMed ID: 37838620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysis.
    Khan MS; Friede T; Anker SD; Butler J
    ESC Heart Fail; 2021 Jun; 8(3):1885-1891. PubMed ID: 33784028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical and haemodynamic results after transcatheter annuloplasty for secondary mitral regurgitation.
    Lavall D; Bruns J; Stegmann T; Hagendorff A; Stöbe S; Laufs U
    ESC Heart Fail; 2021 Aug; 8(4):2448-2457. PubMed ID: 33939295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation.
    Witte KK; Lipiecki J; Siminiak T; Meredith IT; Malkin CJ; Goldberg SL; Stark MA; von Bardeleben RS; Cremer PC; Jaber WA; Celermajer DS; Kaye DM; Sievert H
    JACC Heart Fail; 2019 Nov; 7(11):945-955. PubMed ID: 31521683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Survival Following Transcatheter Mitral Valve Repair: Pooled Analysis of Prospective Trials with the Carillon Device.
    Lipiecki J; Kaye DM; Witte KK; Haude M; Kapadia S; Sievert H; Goldberg SL; Levy WC; Siminiak T
    Cardiovasc Revasc Med; 2020 Jun; 21(6):712-716. PubMed ID: 32111559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Trans-Coronary Venous Mitral Annuloplasty in Patients With Functional Mitral Regurgitation: Analysis of Poznan Carillon Registry Data.
    Kałmucki P; Jerzykowska O; Dankowski R; Baszko A; Kramer L; Szyszka A; Siminiak T
    J Interv Cardiol; 2016 Dec; 29(6):632-638. PubMed ID: 27813186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Rottländer D; Golabkesh M; Degen H; Ögütcü A; Saal M; Haude M
    Catheter Cardiovasc Interv; 2022 May; 99(6):1839-1847. PubMed ID: 35312231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study.
    Schofer J; Siminiak T; Haude M; Herrman JP; Vainer J; Wu JC; Levy WC; Mauri L; Feldman T; Kwong RY; Kaye DM; Duffy SJ; Tübler T; Degen H; Brandt MC; Van Bibber R; Goldberg S; Reuter DG; Hoppe UC
    Circulation; 2009 Jul; 120(4):326-33. PubMed ID: 19597051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.
    Machaalany J; Bilodeau L; Hoffmann R; Sack S; Sievert H; Kautzner J; Hehrlein C; Serruys P; Sénéchal M; Douglas P; Bertrand OF
    Am Heart J; 2013 May; 165(5):761-9. PubMed ID: 23622913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Mitral Annuloplasty: Carillon Device.
    Nagaraja V; Kapadia SR
    Interv Cardiol Clin; 2024 Apr; 13(2):249-255. PubMed ID: 38432767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of dilated cardiomyopathy and severe mitral regurgitation treated using a combined percutaneous approach of MitraClip followed by CARILLON® mitral contour system.
    Abdelrahman N; Chowdhury MA; Al Nooryani A; Elabbassi W
    Cardiovasc Revasc Med; 2016 Dec; 17(8):578-581. PubMed ID: 27543418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating symptoms and reversing remodelling: clinical and echocardiographic 1-year outcomes with percutaneous mitral annuloplasty for mild to moderate secondary mitral regurgitation.
    Witte KK; Kaye DM; Lipiecki J; Siminiak T; Goldberg SL; von Bardeleben RS; Sievert H; Levy WC; Starling RC
    Eur J Heart Fail; 2021 Nov; 23(11):1971-1978. PubMed ID: 34288287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.
    Siminiak T; Wu JC; Haude M; Hoppe UC; Sadowski J; Lipiecki J; Fajadet J; Shah AM; Feldman T; Kaye DM; Goldberg SL; Levy WC; Solomon SD; Reuter DG
    Eur J Heart Fail; 2012 Aug; 14(8):931-8. PubMed ID: 22613584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcomes with Carillon device over 1 year in patients with functional mitral regurgitation of Grades 2+ to 4+: results from the REDUCE-FMR trial.
    Khan MS; Siddiqi TJ; Butler J; Friede T; Levy WC; Witte KK; Lipiecki J; Sievert H; Coats AJS
    ESC Heart Fail; 2021 Apr; 8(2):872-878. PubMed ID: 33619896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of functional mitral regurgitation by percutaneous annuloplasty using the Carillon Mitral Contour System-Currently available data state.
    Bail DH
    J Interv Cardiol; 2017 Apr; 30(2):156-162. PubMed ID: 28247436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between mitral annulus function and mitral regurgitation severity and left atrial remodelling in patients with primary mitral regurgitation.
    Mihaila S; Muraru D; Miglioranza MH; Piasentini E; Aruta P; Cucchini U; Iliceto S; Vinereanu D; Badano LP
    Eur Heart J Cardiovasc Imaging; 2016 Aug; 17(8):918-29. PubMed ID: 26758410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients treated by coronary sinus-based percutaneous annuloplasty: single centre experience.
    Lipiecki J; Fahrat H; Monzy S; Caillot N; Siminiak T; Johnson T; Vogt S; Stark MA; Goldberg SL
    ESC Heart Fail; 2020 Dec; 7(6):3329-3335. PubMed ID: 33047896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-Analysis of Ring Annuloplasty Versus Combined Ring Annuloplasty and Subvalvular Repair for Moderate-to-Severe Functional Mitral Regurgitation.
    Mihos CG; Larrauri-Reyes M; Santana O
    J Card Surg; 2016 Jan; 31(1):31-7. PubMed ID: 26626776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.